1.Cantwell, R, Clutton-Brock, T, Cooper, G et al. Saving mothers’ lives: Reviewing maternal deaths to make motherhood safer: 2006–2008. The eighth report of the confidential enquiries into maternal deaths in the UK. BJOG 2011;188(Suppl 1):1–203.
2.Nieminen, HP, Jokinen, EV, Sairanen, HI. Late results of pediatric cardiac surgery in Finland: A population-based study with 96% follow-up. Circulation. 2001;104:570–5.
3.Papageorghiou, AT, Yu, CKH, Bindra, R, Pandis, G, Nicolaides, KN. Multicentre screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:441–9.
4.Clark, SL. Cardiac disease in pregnancy. Obstet Gynecol Clin North Am 1991;18:237–56.
5.Clark, SL. Labor and delivery in the patient with structural cardiac disease. Clin Perinatol 1986;13:695–703.
6.Siu, SC, Sermer, M, Harrison, DA, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 1997;96:2789–94.
7.Curry, RA, Fletcher, C, Gelson, E, et al. Pulmonary hypertension and pregnancy–a review of 12 pregnancies in nine women. Br J Obstet Gynaecol 2012;119:752–61.
8.Whittemore, R, Hobbins, JC, Engle, MA. Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease. Am J Cardiol 1982;50:641–51.
9.Presbitero, P, Somerville, J, Stone, S, et al. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation 1994;89:2673–6.
10.Chia, P, Raman, S, Tham, SW. The pregnancy outcome of acyanotic heart disease. J Obstet Gynaecol Res 1998;24:267–73.
11.Gleicher, N, Midwall, J, Hochberger, D, et al. Eisenmenger’s syndrome and pregnancy. Obstet Gynecol Surv 1979;34:721–41.
12.Sawhney, H, Suri, V, Vasishta, K, et al. Pregnancy and congenital heart disease—maternal and fetal outcome. Aust N Z J Obstet Gynaecol 1998;38:266–71.
13.Pedersen, LM, Pedersen, TA, Ravn, HB, et al. Outcomes of pregnancy in women with tetralogy of Fallot. Cardiol Young 2008;18:423–9.
14.Canobbio, MM, Mair, DD, van der Velde, M, et al. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 1996;28:763–7.
15.Hameed, AH, Karaalp, IS, Tummala, PP, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 2001;37:893–9.
16.Malhotra, M, Sharma, JB, Tripathii, R, et al. Maternal and fetal outcome in valvular heart disease. Int J Gynaecol Obstet 2004;84:11–16.
17.Burn, J, Brennan, P, Little, J, et al. Recurrence risks in offspring of adults with major heart defects: Results from first cohort of British collaborative study. Lancet 1998;351:311–16.
18.Nora, JJ. From generational studies to a multilevel genetic-environmental interaction. J Am Coll Cardiol 1994;23:1468–71.
19.Gill, HK, Splitt, M, Sharland, GK, Simpson, JM. Patterns of recurrence of congenital heart disease: An analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography. J Am Coll Cardiol 2003;42:923–9.
20.Nora, JJ, Nora, AH. The evolution of specific genetic and environmental counseling in congenital heart diseases. Circulation 1978;57:205–13.
21.Hyett, J, Moscoso, G, Nicolaides, K. Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetuses. Am J Med Genet 1997;69:207–16.
22.Moyano, D, Huggon, IC, Allan, LD. Fetal echocardiography in trisomy 18. Arch Dis Child Fetal Neonatal Ed 2005;90:F520–2.
23.Surerus, E, Huggon, IC, Allan, LD. Turner’s syndrome in fetal life. Ultrasound Obstet Gynecol 2003;22:264–7.
24.Hyett, J, Perdu, M, Sharland, G, et al. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10–14 weeks of gestation: Population based cohort study. BMJ 1999;318:70–1.
25.Makrydimas, G, Sotiriadis, A, Huggon, IC, et al. Nuchal translucency and fetal cardiac defects: A pooled analysis of major fetal echocardiography centers. Am J Obstet Gynecol 2005;192:89–95.
26.Mogra, R, Alabbad, N, Hyett, J. Increased nuchal translucency and congenital heart disease. Early Hum Dev 2012;88:261–7.
27.Atzei, A, Gajewska, K, Huggon, IC, et al. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound Obstet Gynecol 2005;26:154–7.
28.Huggon, IC, Ghi, T, Cook, AC, et al. Fetal cardiac abnormalities identified prior to 14 weeks’ gestation. Ultrasound Obstet Gynecol 2002;20:22–9.
29.Maiz, N, Plasencia, W, Dagklis, T, et al. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness. Ultrasound Obstet Gynecol 2008;31:256–60.
30.Pereira, S, Ganapathy, R, Syngelaki, A, et al. Contribution of fetal tricuspid regurgitation in first-trimester screening for major cardiac defects. Obstet Gynecol 2011;117:1384–91.
31.Rasiah, SV, Publicover, M, Ewer, AK, et al. A systematic review of the accuracy of first-trimester ultrasound examination for detecting major congenital heart disease. Ultrasound Obstet Gynecol 2006;28:110–16.
32.Khalil, A, Nicolaides, KH. Fetal heart defects: Potential and pitfalls of first-trimester detection. Semin Fetal Neonatal Med 2013;18:251–60.
33.Gelson, E, Curry, R, Gatzoulis, MA, et al. Effect of maternal heart disease on fetal growth. Obstet Gynecol 2011;117:886–91.
34.Papageorghiou, AT, Yu, CK, Nicolaides, KH. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2004;18:383–96.
35.Carbillon, L, Challier, JC, Alouini, S, et al. Uteroplacental circulation development: Doppler assessment and clinical importance. Placenta 2001;22:795–9.
36.Sagol, S, Ozkinay, E, Oztekin, K, et al. The comparison of uterine artery Doppler velocimetry with the histopathology of the placental bed. Aust N Z J Obstet Gynaecol 1999;39:324–9.
37.Neilson, JP, Alfirevic, Z. Doppler ultrasound for fetal assessment in high-risk pregnancies. Cochrane Database Syst Rev 2000;(2):CD000073.
38.Madazli, R, Somunkiran, A, Calay, Z, et al. Histomorphology of the placenta and the placental bed of growth restricted foetuses and correlation with the Doppler velocimetries of the uterine and umbilical arteries. Placenta 2003;24:510–16.
39.Karsdorp, VH, van Vugt, JM, Van Geijn, HP, et al. Clinical significance of absent or reversed end diastolic velocity waveforms in umbilical artery. Lancet 1994;344:1664–8.
40.Pattinson, RC, Norman, K, Odendaal, HJ. The role of Doppler velocimetry in the management of high-risk pregnancies. Br J Obstet Gynaecol 1994;101:114–20.
41.Todros, T, Ronco, G, Fianchino, O, et al. Accuracy of the umbilical arteries Doppler flow velocity waveforms in detecting adverse perinatal outcomes in a high-risk population. Acta Obstet Gynecol Scand 1996;75:113–19.
42.Baschat, AA. Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound Obstet Gynecol 2011;37:501–14.
43.Baschat, AA, Gembruch, U, Reiss, I, et al. Relationship between arterial and venous Doppler and perinatal outcome in fetal growth restriction. Ultrasound Obstet Gynecol 2000;16:407–13.
44.Bilardo, CM, Wolf, H, Stigter, RH, et al. Relationship between monitoring parameters and perinatal outcome in severe, early intrauterine growth restriction. Ultrasound Obstet Gynecol 2004;23:119–25.
45.Coomarasamy, A, Fisk, NM, Gee, H, et al. Investigation and Management of the Small-for-Gestational Age Fetus. Guideline No. 31. London: Guidelines and Audit Committee of the Royal College of Obstetricians and Gynaecologists, 2002.
46.Suri, V, Keepanasseril, A, Aggarwal, N, et al. Maternal complete heart block in pregnancy: Analysis of four cases and review. of management. J Obstet Gynaecol Res 2009;35:434–7.
47.Weiss, BM, von Segesser, LK, Alon, E, et al. Outcome of cardiovascular surgery and pregnancy: A systematic review of the period 1984–1996. Am J Obstet Gynecol 1998;179:1643–53.
48.Chambers, CE, Clark, SL. Cardiac surgery during pregnancy. Clin Obstet Gynecol 1994;37:316–23.
49.Pomini, F, Merccogliano, D, Cavaletti, C, et al. Cardiopulmonary bypass in pregnancy. Ann Thorac Surg 1996;61:259–68.
50.Kalra, GS, Arora, R, Khan, JA, et al. Percutaneous mitral commissurotomy for severe mitral stenosis during pregnancy. Cathet Cardiovasc Diagn 1994;33:28–30.
51.Mahli, A, Izdes, S, Coskun, D. Cardiac operations during pregnancy: Review of factors influencing fetal outcome. Ann Thorac Surg 2000;69:1622–6.
52.Sepehripour, AH, Lo, TT, Shipolini, AR, et al. Can pregnant women be safely placed on cardiopulmonary bypass? Interact Cardiovasc Thorac Surg 2012;15:1063–71.
53.Chandrasekhar, S, Cook, CR, Collard, CD. Cardiac surgery in the parturient. Anesth Analg 2009;108:777–85.
54.Cheek, DB, Hughes, SC, Dailey, PA, et al. Effect of halothane on regional cerebral blood flow and cerebral metabolic oxygen consumption in the fetal lamb in utero. Anesthesiology 1987;67:361–6.
55.Liu, PL, Warren, TM, Ostheimer, GW, et al. Foetal monitoring in parturients undergoing surgery unrelated to pregnancy. Can Anaesth Soc J 1985;32:525–32.
56. Conroy, JM, Bailey, MK, Hollon, MF, et al. Anesthesia for open heart surgery in the pregnant patient. South Med J 1989;82:492–5.
57.Salerno, TA, Houck, JP, Barrozo, CA, et al. Retrograde continuous warm blood cardioplegia: A new concept in myocardial protection. Ann Thorac Surg 1991;51:245–9.
58.Khandelwal, M, Rasanen, J, Ludormirski, A, Addonizio, P, Reece, EA. Evaluation of fetal and uterine hemodynamics during maternal cardiopulmonary bypass. Obstet Gynecol 1996;88:667–71.
59.Draper, ES, Manktelow, B, Field, DJ, James, D. Prediction of survival for preterm births by weight and gestational age: Retrospective population based study. BMJ 1999;319:1093–7.